Literature DB >> 21664941

Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.

Elisabetta Ugolotti1, Irene Vanni, Alessandro Raso, Fabio Benzi, Mauro Malnati, Roberto Biassoni.   

Abstract

Specific combinations of killer immunoglobulin-like receptors (KIR) and human leukocyte antigen (HLA) class I molecules characterized by a particular residue 80 are significantly associated with outcomes in different pathologic conditions, such as autoimmunity, pathogenic infection, cancer, and reproductive failure. Thus, a simplified method for HLA typing used in association with the analysis of KIR genotype (Kirotype) is of particular interest to extend the analysis of larger series. Here, we describe a quick and inexpensive method that allows use of pyrosequencing, a helpful subtyping of HLA class I molecules, into HLA-Bw6, -Bw4 I(80) or -Bw4 T(80), HLA-C1, or -C2 groups and HLA-A allotypes sharing Bw4+ epitope or the rare HLA-B allotypes displaying the C1 motif. In particular, this analysis is focused on the amino acids around residue 80, known to be relevant in defining the affinity of KIR/HLA interaction and in the functional effects. This method was demonstrated to have good sensitivity, specificity, and reproducibility of detection and it was validated using a panel of HLA-typed International Histocompatibility Workshop (IHW) cell lines and clinical isolates. Using an allele quantitative acquisition mode, the method permitted us to obtain an accurate sequencing as required in heterozygous and/or homozygous sample definition.
Copyright © 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664941     DOI: 10.1016/j.humimm.2011.05.007

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  2 in total

1.  Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.

Authors:  Lisa E Creary; Sandra G Guerra; Winnie Chong; Colin J Brown; Thomas R Turner; James Robinson; Will P Bultitude; Neema P Mayor; Steven G E Marsh; Katsuyuki Saito; Kevin Lam; Jamie L Duke; Timothy L Mosbruger; Deborah Ferriola; Dimitrios Monos; Amanda Willis; Medhat Askar; Gottfried Fischer; Chee Loong Saw; Jiannis Ragoussis; Martin Petrek; Carles Serra-Pagés; Manel Juan; Catherine Stavropoulos-Giokas; Amalia Dinou; Reem Ameen; Salem Al Shemmari; Eric Spierings; Ketevan Gendzekhadze; Gerald P Morris; Qiuheng Zhang; Zahra Kashi; Susan Hsu; Sridevi Gangavarapu; Kalyan C Mallempati; Fumiko Yamamoto; Kazutoyo Osoegawa; Tamara Vayntrub; Chia-Jung Chang; John A Hansen; Marcelo A Fernández-Viňa
Journal:  Hum Immunol       Date:  2019-03-04       Impact factor: 2.850

2.  Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control.

Authors:  Mauro S Malnati; Elisabetta Ugolotti; Maria Cristina Monti; Davide De Battista; Irene Vanni; Domenico Bordo; Francesca Sironi; Patrizia Larghero; Eddi Di Marco; Priscilla Biswas; Guido Poli; Elisa Vicenzi; Agostino Riva; Maciej Tarkowski; Giuseppe Tambussi; Silvia Nozza; Gino Tripodi; Francesco Marras; Andrea De Maria; Angela Pistorio; Roberto Biassoni
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.